These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 15285029)

  • 1. E-cadherin and calretinin as immunocytochemical markers to differentiate malignant from benign serous effusions.
    He DN; Zhu HS; Zhang KH; Jin WJ; Zhu WM; Li N; Li JS
    World J Gastroenterol; 2004 Aug; 10(16):2406-8. PubMed ID: 15285029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of anti-L523S antibody in the diagnosis of benign and malignant serous effusions.
    Hanley KZ; Facik MS; Bourne PA; Yang Q; Spaulding BO; Bonfiglio TA; Xu H
    Cancer; 2008 Feb; 114(1):49-56. PubMed ID: 18098206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E-cadherin, N-cadherin, and calretinin in pleural effusions: the good, the bad, the worthless.
    Simsir A; Fetsch P; Mehta D; Zakowski M; Abati A
    Diagn Cytopathol; 1999 Mar; 20(3):125-30. PubMed ID: 10086235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of desmin and N-cadherin in effusion cytology: a comparative study using established markers of mesothelial and epithelial cells.
    Davidson B; Nielsen S; Christensen J; Asschenfeldt P; Berner A; Risberg B; Johansen P
    Am J Surg Pathol; 2001 Nov; 25(11):1405-12. PubMed ID: 11684957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of detecting glucose transporter 1 and calretinin in serous effusions to differentiate between carcinoma cells and reactive mesothelial cells.
    Lv M; Cha N; Zou YF; Leng JH; Hao YY; Wang S
    Diagn Cytopathol; 2021 Jul; 49(7):811-816. PubMed ID: 33818924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry.
    Su XY; Li GD; Liu WP; Xie B; Jiang YH
    Diagn Cytopathol; 2011 Dec; 39(12):900-8. PubMed ID: 20836004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calretinin. A selective marker of normal and neoplastic mesothelial cells in serous effusions.
    Barberis MC; Faleri M; Veronese S; Casadio C; Viale G
    Acta Cytol; 1997; 41(6):1757-61. PubMed ID: 9390137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions.
    Davidson B; Berner A; Nesland JM; Risberg B; Berner HS; Tropè CG; Kristensen GB; Bryne M; Ann Florenes V
    J Pathol; 2000 Dec; 192(4):460-9. PubMed ID: 11113863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of combining detection of E-cadherin, carcinoembryonic antigen, and calretinin in cytological differential diagnosis of serous effusion].
    Su XY; Li GD; Liu HB; Jiang LL
    Ai Zheng; 2004 Oct; 23(10):1185-9. PubMed ID: 15473932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calretinin staining pattern aids in the differentiation of mesothelioma from adenocarcinoma in serous effusions.
    Chhieng DC; Yee H; Schaefer D; Cangiarella JF; Jagirdar J; Chiriboga LA; Jagirdar J; Chiriboga LA; Cohen JM
    Cancer; 2000 Jun; 90(3):194-200. PubMed ID: 10896333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a panel of molecular markers for the diagnosis of malignant serous effusions.
    Passebosc-Faure K; Li G; Lambert C; Cottier M; Gentil-Perret A; Fournel P; Pérol M; Genin C
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6862-7. PubMed ID: 16203775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Differential diagnostic value of B72.3, Ber-EP4 and calretinin in serous effusions].
    Li XJ; Pan QJ; Shen GH; Liu XY; Sun YT
    Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):438-41. PubMed ID: 16188134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of p53 and ki67 immunostaining for distinguishing benign from malignant serous effusions.
    Hafez NH; Tahoun NS
    J Egypt Natl Canc Inst; 2011 Dec; 23(4):155-62. PubMed ID: 22776843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytologic malignancy versus benignancy: how useful are the "newer" markers in body fluid cytology?
    Lyons-Boudreaux V; Mody DR; Zhai J; Coffey D
    Arch Pathol Lab Med; 2008 Jan; 132(1):23-8. PubMed ID: 18181669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of monocyte/macrophage cell populations in effusions: a comparative study using flow cytometric immunophenotyping and immunocytochemistry.
    Risberg B; Davidson B; Nielsen S; Dong HP; Christensen J; Johansen P; Asschenfeldt P; Berner A
    Diagn Cytopathol; 2001 Oct; 25(4):214-9. PubMed ID: 11599103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric immunophenotyping of serous effusions and peritoneal washings: comparison with immunocytochemistry and morphological findings.
    Risberg B; Davidson B; Dong HP; Nesland JM; Berner A
    J Clin Pathol; 2000 Jul; 53(7):513-7. PubMed ID: 10961174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The value of immunocytochemistry in differentiating benign and malignant serous effusion].
    Mei P; Luo XL; Liu YH; Zhuang HG; Zhang W; Chen GY
    Zhonghua Bing Li Xue Za Zhi; 2005 Jun; 34(6):368-9. PubMed ID: 16185510
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids.
    Politi E; Kandaraki C; Apostolopoulou C; Kyritsi T; Koutselini H
    Diagn Cytopathol; 2005 Mar; 32(3):151-5. PubMed ID: 15690338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytologic differential diagnosis among reactive mesothelial cells, malignant mesothelioma, and adenocarcinoma: utility of combined E-cadherin and calretinin immunostaining.
    Kitazume H; Kitamura K; Mukai K; Inayama Y; Kawano N; Nakamura N; Sano J; Mitsui K; Yoshida S; Nakatani Y
    Cancer; 2000 Feb; 90(1):55-60. PubMed ID: 10692217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunocytochemical panel for distinguishing between adenocarcinomas and reactive mesothelial cells in effusion cell blocks.
    Kim JH; Kim GE; Choi YD; Lee JS; Lee JH; Nam JH; Choi C
    Diagn Cytopathol; 2009 Apr; 37(4):258-61. PubMed ID: 19217030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.